Neil Carragher
Presidente presso The Corporate Partnership Ltd.
Profilo
Neil Carragher is the founder of Pheno Therapeutics Ltd.
which was founded in 2018.
He is currently the Chairman of The Corporate Partnership Ltd.
Mr. Carragher's former positions include Chairman of NUCRYST Pharmaceuticals Corp.
from 2005 to 2010, and Director positions at Agrium, Inc. and The Westaim Corp.
Mr. Carragher's education includes an undergraduate degree from the University of Glasgow and a graduate degree from the University of London.
Posizioni attive di Neil Carragher
| Società | Posizione | Inizio |
|---|---|---|
| The Corporate Partnership Ltd. | Presidente | - |
Precedenti posizioni note di Neil Carragher
| Società | Posizione | Fine |
|---|---|---|
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Presidente | 09/02/2010 |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Fondatore | - |
| THE WESTAIM CORPORATION | Direttore/Membro del Consiglio | - |
| AGRIUM INC | Direttore/Membro del Consiglio | - |
Formazione di Neil Carragher
| University of Glasgow | Undergraduate Degree |
| University of London | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THE WESTAIM CORPORATION | Finance |
| Aziende private | 4 |
|---|---|
Agrium, Inc.
 Agrium, Inc. Chemicals: AgriculturalProcess Industries Agrium, Inc. engages in the production and distribution of agricultural products, services, and solutions. It operates through the Retail and Wholesale segments. The Retail segment offers crop nutrients, crop protection products, seed, merchandise and services. The Wholesale segment produces, markets, and distributes crop nutrients and industrial products. The company was founded on December 21, 1992 and is headquartered in Calgary, Canada | Process Industries |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
| The Corporate Partnership Ltd. | |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Neil Carragher
